BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7821473)

  • 1. Ivermectin and onchocercal optic neuritis: short-term effects.
    Murdoch I; Abiose A; Babalola O; Bird A; Cousens S; Evans J; Jones B
    Eye (Lond); 1994; 8 ( Pt 4)():456-61. PubMed ID: 7821473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.
    Abiose A; Jones BR; Cousens SN; Murdoch I; Cassels-Brown A; Babalola OE; Alexander ND; Nuhu I; Evans J; Ibrahim UF
    Lancet; 1993 Jan; 341(8838):130-4. PubMed ID: 8093742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of annual dosing with ivermectin on progression of onchocercal visual field loss.
    Cousens SN; Cassels-Brown A; Murdoch I; Babalola OE; Jatau D; Alexander ND; Evans JE; Danboyi P; Abiose A; Jones BR
    Bull World Health Organ; 1997; 75(3):229-36. PubMed ID: 9277010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onchocerciasis as a risk factor for night blindness.
    Babalola OE
    Ophthalmic Epidemiol; 2012 Aug; 19(4):204-10. PubMed ID: 22775275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
    Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis.
    Roed HG; Langkilde A; Sellebjerg F; Lauritzen M; Bang P; Mørup A; Frederiksen JL
    Neurology; 2005 Mar; 64(5):804-10. PubMed ID: 15753413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Control of onchocerciasis with ivermectin: results of a mass campaign in northern Cameroon].
    Prod'hon J; Boussinesq M; Fobi G; Prud'hom JM; Enyong P; Lafleur C; Quillévéré D
    Bull World Health Organ; 1991; 69(4):443-50. PubMed ID: 1934238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
    Dadzie KY; Bird AC; Awadzi K; Schulz-Key H; Gilles HM; Aziz MA
    Br J Ophthalmol; 1987 Feb; 71(2):78-85. PubMed ID: 3548811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
    N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onchocercal eye disease and the impact of Mectizan treatment.
    Abiose A
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S11-22. PubMed ID: 9861263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Short-term effect of megadose steroid therapy in optic neuritis].
    Gerling J; Kommerell G
    Klin Monbl Augenheilkd; 1992 Dec; 201(6):375-80. PubMed ID: 1287359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ivermectin with and without doxycycline on clinical symptoms of onchocerciasis.
    Masud H; Qureshi TQ; Dukley M
    J Coll Physicians Surg Pak; 2009 Jan; 19(1):34-8. PubMed ID: 19149978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic neuritis: characteristics and visual outcome.
    Chuenkongkaew W; Chirapapaisan N
    J Med Assoc Thai; 2003 Mar; 86(3):238-43. PubMed ID: 12757063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin for onchocercal eye disease (river blindness).
    Ejere H; Schwartz E; Wormald R
    Cochrane Database Syst Rev; 2001; (1):CD002219. PubMed ID: 11279760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus.
    Dadzie KY; Remme J; De Sole G
    Trans R Soc Trop Med Hyg; 1991; 85(2):267-71. PubMed ID: 1887490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
    N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin dose assessment without weighing scales.
    Alexander ND; Cousens SN; Yahaya H; Abiose A; Jones BR
    Bull World Health Organ; 1993; 71(3-4):361-6. PubMed ID: 8324855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone.
    Whitworth JA; Gilbert CE; Mabey DM; Maude GH; Morgan D; Taylor DW
    Lancet; 1991 Nov; 338(8775):1100-3. PubMed ID: 1682543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic neuritis with visual field defect--possible Ibuprofen-related toxicity.
    Gamulescu MA; Schalke B; Schuierer G; Gabel VP
    Ann Pharmacother; 2006 Mar; 40(3):571-3. PubMed ID: 16507621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.